Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-21-001084
Filing Date
2021-07-30
Accepted
2021-07-30 17:27:44
Documents
2
Period of Report
2021-07-28

Document Format Files

Seq Description Document Type Size
1 e620828_4-nuvalent.html 4  
1 e620828_4-nuvalent.xml 4 10242
2 e620828_ex99.htm EX-99 3242
  Complete submission text file 0001193805-21-001084.txt   15528
Mailing Address 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010 2125511600
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (Reporting) CIK: 0001009258 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-40671 | Film No.: 211133753

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Reporting) CIK: 0001352546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40671 | Film No.: 211133754

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Issuer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations